Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar;26(Suppl 1):35-37.
doi: 10.1007/s00520-018-4121-5. Epub 2018 Mar 19.

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-concluding thoughts

Matti Aapro  1
Affiliations
Editorial

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-concluding thoughts

Matti Aapro. Support Care Cancer. 2018 Mar.
No abstract available

Keywords: 5-HT3 receptor antagonist; Antiemetic therapy; CINV; Chemotherapy-induced nausea and vomiting; NK-1 receptor antagonist.

PubMed Disclaimer

Conflict of interest statement

Dr. Aapro has disclosed that he has received consulting fees or honoraria from Amgen. He has also received payment for lectures and/or support for travel from Amgen, Helsinn, Hospira, Johnson & Johnson, Novartis, Pierre Fabre Medicament, Roche, Sandoz, TESARO, Teva, and Vifor Pharma. Dr. Aapro has received research funding from Helsinn, Hospira, Novartis, Pierre Fabre Medicament, and Sandoz. He has also disclosed receiving fees for participation in advisory or review activities from Helsinn Healthcare, Hospira, Merck, Merck KGaA, Pierre Fabre Medicament, Sandoz, TESARO, Teva, and Vifor Pharma.

References

    1. Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;374:1356–1367. doi: 10.1056/NEJMra1515442. - DOI - PubMed
    1. Roila F, Molassiotis A, Herrstedt J, participants of the MASCC/ESMO Consensus Conference Copenhagen 2015 et al (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(suppl 5):v119-v133. Available at: 10.1093/annonc/mdw270 - PubMed
    1. National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology. Antiemesis Version 2.2017. Available at: www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed 30 May 2017
    1. Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35:3240–3261. doi: 10.1200/JCO.2017.74.4789. - DOI - PubMed
    1. Costa AL, Abreu C, Pacheco TR, et al. Prevention of nausea and vomiting in patients undergoing oral anticancer therapies for solid tumors. Biomed Res Int. 2015;2015:309601. - PMC - PubMed

Publication types

LinkOut - more resources